Destiny Pharma plc (“Destiny Pharma” or “the Company”) Phase 2b clinical trial of XF-73 completes patient recruitment   Results expected in Q1 2021 Brighton, United Kingdom – 5th January 2021 … Continue reading 05 Jan 2021 – Phase 2b trial of XF-73 completes recruitment